While the vast majority of GLP-1 axons in the spinal cord evidently originates from lower brainstem neurons 9,20 , PPG-promoter driven transgene expression suggested that GLP-1 may be produced locally by a small population of neurons 20
In the liver, insulin resistance promotes de novo lipogenesis (new fat synthesis) and impairs fat oxidation, leading to hepatic steatosis
Your optimal timing is a function of your unique physiology, your daily routine, your side effect sensitivity, and your eating patterns
Cardiovascular considerations Oral estrogen slightly increases the risk of venous thromboembolism (blood clots)
Before starting a GLP-1 medication, your doctor reviews your labs, current medications, and health history to determine if it's appropriate and to catch any red flags a questionnaire-based provider might miss
Understanding the Mental Tug-of-War in Binge Eating The Science of Appetite: How Weight Loss Meds Interact with the Binge Brain Navigating the Risks: When Appetite Suppression Meets Binge Eating Recovery The "Rebound" Reality: What Happens After You Stop GLP-1 Medications